Active: new fund Nov 2025 Verified 5 Nov 2026
Medicxi
European life sciences investor, set up in 2016 by the former Index Ventures life sciences team, that creates and invests in biotech companies from discovery stage through to late-stage clinical development, currently from its Fund V.
- Type
- VC firm
- Location
- London, United Kingdom
- Stages
- Pre-seed, Seed, Series A, Series B, Late stage
- Backs
- Biotech and pharma
- Sectors
- Healthtech and life sciences, Biotech
- Fund size / AUM
- €500 million Fund V (own site, announced 14 Nov 2025)
- Latest fund or filing
- 14 Nov 2025
- Website
- www.medicxi.com
Contacts on file
For Medicxi, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.
Get UK Complete, $149 Free sample
One-time payment. No subscription. No account.
Notable investments
Vaderis TherapeuticsEthyreal BioCentessa PharmaceuticalsVicebioOttimo Pharma
Sources
- www.medicxi.com/
- www.medicxi.com/team
- www.medicxi.com/sections/about
- www.medicxi.com/contact
- www.medicxi.com/news-room
- www.medicxi.com/sections/approach
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 27 lists
Biotech investors in London (42)Series B investors in the UK (54)Active startup investors in the UK (73)Series B biotech investors (73)Biotech investors in the UK (92)Healthtech investors in London (113)Pre-seed biotech investors (148)Venture capital firms in London (149)Series A biotech investors (153)Series A investors in the UK (154)Series B healthtech investors (160)Pre-seed investors in the UK (175)Venture capital firms in the UK (192)Healthtech investors in the UK (194)Startup investors in London (239)Seed investors in the UK (295)Seed biotech investors (300)Series B investors (339)Series A healthtech investors (401)Pre-seed healthtech investors (408)Startup investors in the UK (416)Biotech investors (484)Seed healthtech investors (800)Series A investors (864)Pre-seed investors (988)Healthtech investors (1,207)Seed investors (1,892)